Neuland Laboratories, 524558, NEULANDLAB Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

15,358.85
59.05
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

15,236.04
0.10%
10.08

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.22
9.53
7.43

EBITDA CAGR (%)

10 Years
5 Years
3 Years

14.92
17.10
3.53

PAT CAGR (%)

10 Years
5 Years
3 Years

25.27
26.40
16.73

P:E (Median)

8 Years
5 Years
3 Years

32.55
29.08
27.01

P:BV (Average)

8 Years
5 Years
3 Years

4.03
4.97
6.66

EV:EBITDA (Average)

8 Years
5 Years
3 Years

17.43
19.27
22.68

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS 233.89 201.63 297.48 411.3
P/E Ratio 51.17 59.36 40.23 29.10
Revenue 1516 1477 1951 2412
EBITDA 463 323 579 780
Net Income 300 260 383 529
ROA 17.6 13
P/B Ratio 12.03 10.13 8.26 6.55
ROE 26.36 18.53 20.72 23.37
FCFF 112 113 232 331
FCFF Yield 0.8 0.81 1.66 2.37
Net Debt -21 -228
BVPS 994.97 1181.97 1449.64 1827.66

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 328.36 385.01 -14.71% 398.03 392.83 1.32% 310.84 417.75 -25.59% 439.60 362.99 21.11%
Expenses 277.61 278.22 -0.22% 311.66 272.26 14.47% 249.50 280.45 -11.04% 315.78 265.73 18.83%
EBITDA 50.75 106.79 -52.48% 86.38 120.56 -28.35% 61.34 137.30 -55.32% 123.83 97.27 27.31%
EBIDTM 15.46% 27.74% 21.70% 30.69% 19.73% 32.87% 28.17% 26.80%
Other Income 7.46 5.36 39.18% 3.91 2.10 86.19% 4.33 3.05 41.97% 4.81 2.04 135.78%
Interest 2.35 3.61 -34.90% 2.22 3.74 -40.64% 1.06 4.43 -76.07% 2.67 2.21 20.81%
Depreciation 16.89 16.46 2.61% 16.30 15.14 7.66% 16.07 14.51 10.75% 16.28 13.59 19.79%
PBT 38.98 92.08 -57.67% 127.55 103.78 22.90% 48.54 121.41 -60.02% 130.31 83.50 56.06%
Tax 11.25 24.47 -54.03% 26.15 23.08 13.30% 16.58 32.34 -48.73% 31.97 21.28 50.23%
PAT 27.73 67.61 -58.99% 101.39 80.70 25.64% 31.96 89.06 -64.11% 98.34 62.22 58.05%
PATM 8.45% 17.56% 25.47% 20.54% 10.28% 21.32% 22.37% 17.14%
EPS 21.67 52.82 -58.97% 79.21 63.05 25.63% 24.97 69.58 -64.11% 76.83 48.61 58.05%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 328.36 385.01 -14.71% 398.03 392.83 1.32% 310.84 417.75 -25.59% 439.60 362.99 21.11%
Expenses 277.29 278.09 -0.29% 311.43 271.56 14.68% 248.62 280.26 -11.29% 316.24 266.07 18.86%
EBITDA 51.07 106.92 -52.24% 86.60 121.27 -28.59% 62.23 137.49 -54.74% 123.36 96.92 27.28%
EBIDTM 15.55% 27.77% 21.76% 30.87% 20.02% 32.91% 28.06% 26.70%
Other Income 7.46 5.36 39.18% 3.91 2.10 86.19% 4.33 3.05 41.97% 4.81 2.04 135.78%
Interest 2.35 3.61 -34.90% 2.22 3.74 -40.64% 1.06 4.43 -76.07% 2.67 2.21 20.81%
Depreciation 16.89 16.46 2.61% 16.30 15.14 7.66% 16.07 14.51 10.75% 16.28 13.59 19.79%
PBT 39.30 92.20 -57.38% 127.77 104.48 22.29% 49.42 121.59 -59.36% 129.84 83.16 56.13%
Tax 11.49 24.64 -53.37% 26.18 23.09 13.38% 16.58 32.35 -48.75% 31.97 21.28 50.23%
PAT 27.80 67.56 -58.85% 101.59 81.39 24.82% 32.84 89.25 -63.20% 97.87 61.88 58.16%
PATM 8.47% 17.55% 25.52% 20.72% 10.57% 21.36% 22.26% 17.05%
EPS 21.55 52.37 -58.85% 78.75 63.09 24.82% 25.46 69.18 -63.20% 75.86 47.96 58.17%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales - 1,476.84 1,558.58 1,191.20 951.08 936.91 762.71 666.83 527.41 578.89 509.97 Net Sales Growth - -5.24% 30.84% 25.25% 1.51% 22.84% 14.38% 26.43% -8.89% 13.51% Cost Of Goods Sold - 587.64 577.29 478.23 422.14 438.42 380.20 366.24 238.37 262.90 253.46 Gross Profit - 889.20 981.30 712.97 528.94 498.50 382.51 300.59 289.04 315.99 256.52 GP Margin - 60.21% 62.96% 59.85% 55.61% 53.21% 50.15% 45.08% 54.80% 54.59% 50.30% Total Expenditure - 1,154.54 1,096.66 919.89 808.88 790.47 661.25 608.96 477.38 473.20 430.10 Power & Fuel Cost - 50.56 48.72 48.62 42.21 39.21 32.75 26.81 25.95 25.78 22.24 % Of Sales - 3.42% 3.13% 4.08% 4.44% 4.19% 4.29% 4.02% 4.92% 4.45% 4.36% Employee Cost - 261.40 248.53 194.84 175.76 144.02 118.48 104.47 95.73 84.92 59.89 % Of Sales - 17.70% 15.95% 16.36% 18.48% 15.37% 15.53% 15.67% 18.15% 14.67% 11.74% Manufacturing Exp. - 112.31 107.79 86.94 89.16 77.10 64.84 50.10 55.54 44.90 39.31 % Of Sales - 7.60% 6.92% 7.30% 9.37% 8.23% 8.50% 7.51% 10.53% 7.76% 7.71% General & Admin Exp. - 78.46 68.84 48.24 34.50 37.42 25.18 24.56 30.38 25.23 26.90 % Of Sales - 5.31% 4.42% 4.05% 3.63% 3.99% 3.30% 3.68% 5.76% 4.36% 5.27% Selling & Distn. Exp. - 42.06 35.45 40.25 36.00 42.38 26.59 28.01 26.50 23.14 26.41 % Of Sales - 2.85% 2.27% 3.38% 3.79% 4.52% 3.49% 4.20% 5.02% 4.00% 5.18% Miscellaneous Exp. - 22.11 10.04 22.77 9.12 11.93 13.21 8.76 4.91 6.34 26.41 % Of Sales - 1.50% 0.64% 1.91% 0.96% 1.27% 1.73% 1.31% 0.93% 1.10% 0.37% EBITDA - 322.30 461.92 271.31 142.20 146.44 101.46 57.87 50.03 105.69 79.87 EBITDA Margin - 21.82% 29.64% 22.78% 14.95% 15.63% 13.30% 8.68% 9.49% 18.26% 15.66% Other Income - 20.51 12.54 9.75 2.08 16.09 3.89 3.49 4.53 1.17 1.62 Interest - 8.30 14.00 13.07 13.49 17.90 21.57 15.66 18.92 21.08 24.47 Depreciation - 65.54 59.70 52.78 49.04 39.68 31.28 25.86 22.10 19.23 15.74 PBT - 268.97 400.77 215.21 81.74 104.96 52.50 19.84 13.54 66.55 41.28 Tax - 85.95 101.17 52.09 18.21 24.67 36.62 3.69 1.73 20.17 14.87 Tax Rate - 24.89% 25.24% 24.20% 22.28% 23.50% 69.75% 18.60% 12.78% 30.31% 36.02% PAT - 259.43 299.60 163.12 63.53 80.29 15.88 16.14 11.81 46.38 26.41 PAT before Minority Interest - 259.43 299.60 163.12 63.53 80.29 15.88 16.14 11.81 46.38 26.41 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 17.57% 19.22% 13.69% 6.68% 8.57% 2.08% 2.42% 2.24% 8.01% 5.18% PAT Growth - -13.41% 83.67% 156.76% -20.87% 405.60% -1.61% 36.66% -74.54% 75.62% EPS - 202.68 234.06 127.44 49.63 62.73 12.41 12.61 9.23 36.23 20.63

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales - 1,476.84 1,558.58 1,191.20 951.08 936.91 762.71 666.83 527.41 578.89 509.97 Net Sales Growth - -5.24% 30.84% 25.25% 1.51% 22.84% 14.38% 26.43% -8.89% 13.51% Cost Of Goods Sold - 587.64 577.29 478.23 422.14 438.42 380.20 366.24 238.37 262.90 253.46 Gross Profit - 889.20 981.30 712.97 528.94 498.50 382.51 300.59 289.04 315.99 256.52 GP Margin - 60.21% 62.96% 59.85% 55.61% 53.21% 50.15% 45.08% 54.80% 54.59% 50.30% Total Expenditure - 1,153.58 1,095.99 919.36 808.46 790.09 660.82 608.46 476.98 472.55 429.52 Power & Fuel Cost - 50.56 48.72 48.62 42.21 39.21 32.75 26.81 25.95 25.78 22.24 % Of Sales - 3.42% 3.13% 4.08% 4.44% 4.19% 4.29% 4.02% 4.92% 4.45% 4.36% Employee Cost - 272.00 257.06 201.79 182.47 149.74 123.56 110.46 102.99 92.74 65.38 % Of Sales - 18.42% 16.49% 16.94% 19.19% 15.98% 16.20% 16.56% 19.53% 16.02% 12.82% Manufacturing Exp. - 112.31 107.79 86.94 89.16 77.10 64.84 50.10 55.54 44.90 39.31 % Of Sales - 7.60% 6.92% 7.30% 9.37% 8.23% 8.50% 7.51% 10.53% 7.76% 7.71% General & Admin Exp. - 67.29 60.91 51.22 35.80 38.93 27.75 27.49 33.32 28.30 29.72 % Of Sales - 4.56% 3.91% 4.30% 3.76% 4.16% 3.64% 4.12% 6.32% 4.89% 5.83% Selling & Distn. Exp. - 41.35 33.94 29.58 27.40 34.63 18.30 18.28 14.04 11.16 17.52 % Of Sales - 2.80% 2.18% 2.48% 2.88% 3.70% 2.40% 2.74% 2.66% 1.93% 3.44% Miscellaneous Exp. - 22.42 10.29 22.99 9.28 12.08 13.42 9.08 6.77 6.78 17.52 % Of Sales - 1.52% 0.66% 1.93% 0.98% 1.29% 1.76% 1.36% 1.28% 1.17% 0.37% EBITDA - 323.26 462.59 271.84 142.62 146.82 101.89 58.37 50.43 106.34 80.45 EBITDA Margin - 21.89% 29.68% 22.82% 15.00% 15.67% 13.36% 8.75% 9.56% 18.37% 15.78% Other Income - 20.51 12.54 9.75 2.08 16.10 3.89 3.49 4.53 1.17 1.78 Interest - 8.30 14.00 13.07 13.50 17.90 21.57 15.66 18.93 21.09 24.48 Depreciation - 65.55 59.70 52.78 49.04 39.68 31.28 25.86 22.10 19.23 15.74 PBT - 269.93 401.44 215.75 82.16 105.33 52.92 20.34 13.93 67.19 42.00 Tax - 86.22 101.36 52.23 18.34 24.70 36.71 3.90 1.87 20.32 14.92 Tax Rate - 24.90% 25.25% 24.21% 22.32% 23.45% 69.37% 19.17% 13.42% 30.24% 35.52% PAT - 260.11 300.08 163.52 63.82 80.63 16.21 16.44 12.06 46.86 27.33 PAT before Minority Interest - 260.11 300.08 163.52 63.82 80.63 16.21 16.44 12.06 46.86 27.08 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.25 PAT Margin - 17.61% 19.25% 13.73% 6.71% 8.61% 2.13% 2.47% 2.29% 8.09% 5.36% PAT Growth - -13.32% 83.51% 156.22% -20.85% 397.41% -1.40% 36.32% -74.26% 71.46% EPS - 203.21 234.44 127.75 49.86 62.99 12.66 12.84 9.42 36.61 21.35

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 1,517.79 1,276.54 988.36 835.57 781.88 705.55 695.58 554.78 542.78 184.17 Share Capital 12.90 12.90 12.90 12.90 12.90 12.90 12.90 8.95 8.95 8.95 Total Reserves 1,504.89 1,263.64 975.46 822.67 768.98 692.64 682.68 234.98 222.97 175.22 Non-Current Liabilities 187.54 120.59 145.22 178.42 168.68 162.21 103.13 145.78 53.83 69.01 Secured Loans 90.73 44.92 74.25 104.25 88.13 77.37 60.72 103.49 29.81 33.40 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 12.00 Long Term Provisions 6.64 7.13 9.83 11.45 9.10 12.18 11.74 9.87 9.28 6.85 Current Liabilities 472.84 433.80 445.75 368.13 372.96 361.99 331.19 370.38 288.24 270.16 Trade Payables 260.90 198.54 177.99 122.65 156.75 120.00 124.00 129.01 88.64 86.17 Other Current Liabilities 209.84 233.63 244.71 152.05 158.59 71.55 57.33 40.57 47.11 54.90 Short Term Borrowings 0.00 0.00 11.16 92.21 56.98 168.17 149.06 199.20 151.08 123.63 Short Term Provisions 2.10 1.64 11.89 1.21 0.64 2.27 0.80 1.59 1.41 5.47 Total Liabilities 2,178.17 1,830.93 1,579.33 1,382.12 1,323.52 1,229.75 1,129.90 1,070.94 884.85 523.34 Net Block 954.89 804.63 738.19 747.70 696.92 622.75 511.67 445.01 435.74 138.77 Gross Block 1,238.17 1,069.73 953.24 913.24 826.45 714.31 575.42 483.45 454.74 291.78 Accumulated Depreciation 283.28 265.10 215.05 165.54 129.53 91.56 63.75 38.44 19.00 153.00 Non Current Assets 1,040.35 911.46 819.00 802.87 775.34 715.91 676.96 624.22 510.60 210.00 Capital Work in Progress 47.66 45.89 40.57 20.46 17.25 23.75 104.47 126.09 19.60 40.48 Non Current Investment 1.69 1.44 0.68 0.66 19.50 30.33 30.37 30.37 30.36 7.55 Long Term Loans & Adv. 35.88 40.31 20.21 14.40 41.66 35.78 30.45 22.52 24.69 22.71 Other Non Current Assets 0.23 0.17 0.00 0.00 0.00 3.30 0.00 0.22 0.22 0.50 Current Assets 1,137.82 919.47 760.34 579.25 548.18 513.83 452.93 446.73 374.24 313.34 Current Investments 107.68 0.00 0.00 3.38 6.46 7.50 7.50 7.50 7.50 0.00 Inventories 385.76 350.42 279.23 265.21 247.61 219.55 192.65 175.09 135.11 126.66 Sundry Debtors 315.72 373.53 361.77 234.33 217.73 189.89 164.02 193.92 181.11 119.11 Cash & Bank 257.27 115.29 58.65 18.99 18.08 45.69 37.35 17.05 12.04 9.04 Other Current Assets 71.39 18.27 13.66 11.39 58.30 51.21 51.41 53.17 38.47 58.53 Short Term Loans & Adv. 51.75 61.96 47.03 45.95 49.54 33.79 31.77 36.93 25.03 46.54 Net Current Assets 664.98 485.67 314.59 211.12 175.22 151.84 121.74 76.35 86.00 43.18 Total Assets 2,178.17 1,830.93 1,579.34 1,382.12 1,323.52 1,229.74 1,129.89 1,070.95 884.84 523.34

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 1,524.81 1,282.70 994.10 840.50 786.46 709.96 699.31 558.04 545.62 186.63 Share Capital 12.90 12.90 12.90 12.90 12.90 12.90 12.90 8.95 8.95 8.95 Total Reserves 1,511.91 1,269.80 981.20 827.60 773.56 697.06 686.41 238.24 225.81 177.68 Non-Current Liabilities 189.39 122.17 146.71 179.83 169.82 163.39 104.06 146.43 54.37 69.42 Secured Loans 90.73 44.92 74.25 104.25 88.13 77.37 60.72 103.49 29.81 33.40 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 12.00 Long Term Provisions 7.22 7.61 10.29 11.91 9.44 12.49 11.91 9.87 9.28 6.85 Current Liabilities 465.69 427.68 438.96 363.16 368.51 357.63 326.98 366.93 285.60 268.00 Trade Payables 252.20 191.96 171.01 117.38 152.13 115.56 119.68 124.29 85.92 83.86 Other Current Liabilities 211.30 234.01 244.87 152.35 158.75 71.63 57.45 41.83 47.18 55.02 Short Term Borrowings 0.00 0.00 11.16 92.21 56.98 168.17 149.06 199.20 151.08 123.63 Short Term Provisions 2.19 1.72 11.93 1.21 0.64 2.27 0.80 1.59 1.41 5.50 Total Liabilities 2,179.89 1,832.55 1,579.77 1,383.49 1,324.79 1,230.98 1,130.35 1,071.40 885.59 524.05 Net Block 954.92 804.64 738.19 747.70 696.94 622.76 511.69 445.01 435.74 138.77 Gross Block 1,238.23 1,069.76 950.36 913.27 826.48 714.33 575.44 483.45 454.74 291.78 Accumulated Depreciation 283.31 265.12 212.17 165.57 129.54 91.57 63.75 38.44 19.00 153.00 Non Current Assets 1,040.38 911.48 818.87 802.70 775.20 715.79 676.88 624.20 510.54 209.87 Capital Work in Progress 47.66 45.89 40.57 20.46 17.25 23.75 104.47 126.09 19.60 40.48 Non Current Investment 1.53 1.28 0.52 0.50 19.35 30.17 30.21 30.21 30.20 7.39 Long Term Loans & Adv. 36.04 40.47 20.24 14.38 41.67 35.81 30.51 22.66 24.79 22.73 Other Non Current Assets 0.23 0.17 0.00 0.00 0.00 3.30 0.00 0.22 0.22 0.50 Current Assets 1,139.50 921.08 760.89 580.79 549.59 515.19 453.47 447.19 375.04 314.19 Current Investments 107.68 0.00 0.00 3.38 6.46 7.50 7.50 7.50 7.50 0.00 Inventories 385.76 350.42 279.23 265.21 247.61 219.55 192.65 175.09 135.11 126.66 Sundry Debtors 315.72 373.53 361.77 234.33 217.73 189.89 164.02 193.92 181.11 119.11 Cash & Bank 258.82 116.80 59.10 20.36 19.40 46.98 37.84 17.26 12.49 9.71 Other Current Assets 71.52 18.30 13.70 11.52 58.39 51.27 51.46 53.43 38.83 58.70 Short Term Loans & Adv. 51.82 62.03 47.09 46.00 49.55 33.80 31.77 37.15 25.30 46.68 Net Current Assets 673.81 493.40 321.94 217.64 181.08 157.55 126.49 80.27 89.45 46.18 Total Assets 2,179.88 1,832.56 1,579.76 1,383.49 1,324.79 1,230.98 1,130.35 1,071.39 885.58 524.06

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 317.49 260.06 238.53 60.41 189.28 56.63 69.60 11.52 38.89 44.65 PBT 345.37 400.77 215.21 81.74 104.96 52.50 19.84 13.54 66.55 41.28 Adjustment -12.01 62.07 77.93 66.18 40.17 58.14 38.93 40.35 43.95 33.85 Changes in Working Capital 58.75 -91.22 -11.04 -66.99 49.34 -49.30 15.92 -39.20 -55.25 -18.76 Cash after chg. in Working capital 392.11 371.63 282.10 80.93 194.47 61.33 74.68 14.69 55.25 56.38 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -74.62 -111.57 -43.57 -20.53 -5.19 -4.70 -5.09 -3.17 -16.36 -11.73 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -298.14 -149.67 -61.50 -95.53 -84.42 -48.68 -77.22 -116.29 -42.11 -19.86 Net Fixed Assets -170.21 -121.81 -60.11 -90.00 -105.64 -58.17 -70.35 -135.20 -142.08 -27.14 Net Investments -107.93 -0.76 3.36 21.92 11.87 0.04 0.00 -0.01 -30.31 0.12 Others -20.00 -27.10 -4.75 -27.45 9.35 9.45 -6.87 18.92 130.28 7.16 Cash from Financing Activity 24.96 -69.28 -135.80 37.72 -113.66 -5.48 11.98 104.86 -0.08 -23.62 Net Cash Inflow / Outflow 44.31 41.11 41.24 2.60 -8.80 2.47 4.36 0.09 -3.30 1.18 Opening Cash & Equivalents 86.07 44.96 3.72 1.12 9.92 7.44 3.08 3.00 6.29 0.32 Closing Cash & Equivalent 130.38 86.07 44.96 3.72 1.12 9.92 7.44 3.08 3.00 1.49

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 317.38 261.18 237.21 60.39 189.36 57.34 69.91 11.27 38.68 44.83 PBT 346.33 401.44 215.75 82.16 105.33 52.92 20.34 13.93 67.19 42.00 Adjustment -12.00 62.08 77.93 66.30 40.08 58.28 39.11 40.43 43.96 33.73 Changes in Working Capital 57.78 -90.73 -12.83 -67.58 49.22 -49.17 15.47 -40.02 -55.94 -19.17 Cash after chg. in Working capital 392.11 372.78 280.84 80.88 194.63 62.03 74.91 14.35 55.20 56.56 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -74.73 -111.60 -43.63 -20.49 -5.27 -4.68 -5.01 -3.08 -16.52 -11.73 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -298.16 -149.69 -61.50 -95.52 -84.42 -48.68 -77.23 -116.29 -42.11 -19.86 Net Fixed Assets -170.21 -121.81 -60.11 -90.00 -105.64 -58.17 -70.35 -135.20 -142.08 -27.14 Net Investments -107.93 -0.76 3.36 21.92 11.87 0.04 0.00 -0.01 -30.31 0.12 Others -20.02 -27.12 -4.75 -27.44 9.35 9.45 -6.88 18.92 130.28 7.16 Cash from Financing Activity 24.96 -69.28 -135.80 37.72 -113.66 -5.48 11.98 104.85 -0.09 -23.62 Net Cash Inflow / Outflow 44.19 42.21 39.92 2.59 -8.72 3.18 4.66 -0.17 -3.51 1.35 Opening Cash & Equivalents 87.58 45.42 5.09 2.44 11.20 7.94 3.29 3.44 6.97 0.81 Closing Cash & Equivalent 131.93 87.58 45.42 5.09 2.44 11.20 7.94 3.29 3.44 2.16

Financial Ratios

Consolidated /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 1182.30 994.26 769.65 650.56 608.71 549.21 541.45 273.54 260.03 206.30 ROA 12.94% 17.57% 11.02% 4.70% 6.29% 1.35% 1.47% 1.21% 6.59% 5.11% ROE 18.58% 26.48% 17.90% 7.86% 10.81% 2.27% 3.44% 4.98% 22.39% 15.44% ROCE 23.49% 33.62% 20.99% 9.44% 12.83% 7.84% 3.95% 4.04% 15.94% 18.46% Fixed Asset Turnover 1.28 1.54 1.28 1.09 1.22 1.18 1.26 1.13 1.57 1.86 Receivable days 85.17 86.10 91.33 86.74 79.40 84.68 97.96 129.34 93.22 87.45 Inventory Days 90.97 73.73 83.41 98.40 91.00 98.63 100.64 106.98 81.29 84.66 Payable days 142.69 119.04 114.73 120.79 115.20 67.56 78.05 84.05 68.43 85.33 Cash Conversion Cycle 33.46 40.79 60.01 64.36 55.20 115.76 120.56 152.27 106.08 86.78 Total Debt/Equity 0.09 0.06 0.12 0.28 0.22 0.37 0.33 1.31 0.83 0.99 Interest Cover 42.63 29.63 17.47 7.06 6.86 3.43 2.27 1.72 4.16 2.69

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 1187.77 999.07 774.12 654.40 612.28 552.65 544.35 277.21 263.23 209.07 ROA 12.97% 17.59% 11.04% 4.71% 6.31% 1.37% 1.49% 1.23% 6.65% 5.23% ROE 18.54% 26.38% 17.84% 7.85% 10.79% 2.30% 3.48% 5.02% 22.34% 15.64% ROCE 23.45% 33.51% 20.94% 9.44% 12.81% 7.85% 3.99% 4.07% 15.98% 18.57% Fixed Asset Turnover 1.28 1.54 1.28 1.09 1.22 1.18 1.26 1.13 1.57 1.86 Receivable days 85.17 86.10 91.33 86.74 79.40 84.68 97.96 129.34 93.22 87.45 Inventory Days 90.97 73.73 83.41 98.40 91.00 98.63 100.64 106.98 81.29 84.66 Payable days 137.94 114.75 110.05 116.52 111.44 65.43 75.72 82.06 67.03 85.01 Cash Conversion Cycle 38.21 45.08 64.68 68.63 58.96 117.88 122.89 154.27 107.48 87.10 Total Debt/Equity 0.09 0.06 0.12 0.28 0.22 0.37 0.33 1.30 0.82 0.98 Interest Cover 42.74 29.68 17.51 7.09 6.89 3.45 2.30 1.74 4.19 2.72

Top Investors:

malabar india fund limited

mukul mahavir agrawal

hsbc focused fund

siddharth iyer

icici prudential flexicap fund

matthews india fund

jupiter india fund

kedia securities private limited

investor education and protection fund (iepf)

Annual Reports:

News Update:

USFDA inspects Neuland Laboratories’ Unit 2 manufacturing facility in Telangana
3rd May 2025, 16:22 PM

The FDA issued Form 483, with one observation related to building and facility management
Read More

Neuland Laboratories Ltd.

Pharmaceuticals & Drugs - API

BSE: 524558 | NSE: NEULANDLAB

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Neuland Laboratories Ltd.

Pharmaceuticals & Drugs - API

BSE: 524558 | NSE: NEULANDLAB

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: